rs11191017

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_033637.4(BTRC):​c.157-8174G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 152,164 control chromosomes in the GnomAD database, including 1,854 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1854 hom., cov: 32)

Consequence

BTRC
NM_033637.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.409

Publications

5 publications found
Variant links:
Genes affected
BTRC (HGNC:1144): (beta-transducin repeat containing E3 ubiquitin protein ligase) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class; in addition to an F-box, this protein contains multiple WD-40 repeats. The encoded protein mediates degradation of CD4 via its interaction with HIV-1 Vpu. It has also been shown to ubiquitinate phosphorylated NFKBIA (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha), targeting it for degradation and thus activating nuclear factor kappa-B. Alternatively spliced transcript variants have been described. A related pseudogene exists in chromosome 6. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033637.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BTRC
NM_033637.4
MANE Select
c.157-8174G>A
intron
N/ANP_378663.1Q9Y297-1
BTRC
NM_001256856.2
c.156+23355G>A
intron
N/ANP_001243785.1B7Z3H4
BTRC
NM_003939.5
c.49-8174G>A
intron
N/ANP_003930.1Q9Y297-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BTRC
ENST00000370187.8
TSL:1 MANE Select
c.157-8174G>A
intron
N/AENSP00000359206.3Q9Y297-1
BTRC
ENST00000393441.8
TSL:1
c.156+23355G>A
intron
N/AENSP00000377088.5B7Z3H4
BTRC
ENST00000408038.6
TSL:1
c.49-8174G>A
intron
N/AENSP00000385339.2Q9Y297-2

Frequencies

GnomAD3 genomes
AF:
0.138
AC:
20909
AN:
152046
Hom.:
1854
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0427
Gnomad AMI
AF:
0.214
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.179
Gnomad EAS
AF:
0.0369
Gnomad SAS
AF:
0.0931
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.197
Gnomad OTH
AF:
0.143
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.137
AC:
20899
AN:
152164
Hom.:
1854
Cov.:
32
AF XY:
0.135
AC XY:
10064
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0426
AC:
1770
AN:
41540
American (AMR)
AF:
0.129
AC:
1978
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.179
AC:
621
AN:
3466
East Asian (EAS)
AF:
0.0370
AC:
192
AN:
5186
South Asian (SAS)
AF:
0.0934
AC:
450
AN:
4820
European-Finnish (FIN)
AF:
0.181
AC:
1919
AN:
10580
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.197
AC:
13420
AN:
67966
Other (OTH)
AF:
0.142
AC:
300
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
879
1759
2638
3518
4397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.181
Hom.:
1441
Bravo
AF:
0.130
Asia WGS
AF:
0.0520
AC:
180
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.5
DANN
Benign
0.33
PhyloP100
0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11191017; hg19: chr10-103213564; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.